LifeVantage (LFVN)
Provides nutrigenomic wellness products to customers and independent consultants.
Something off on this page? Send us feedback.
Develops nutrigenomic health-and-wellness products rooted in the Protandim line and expanded with LoveBiome’s microbiome-health operating assets. Products are provided to customers and independent consultants, who participate in a commission-based direct-sales opportunity.
Originating with Protandim, the portfolio now includes nutrigenomic health-and-wellness products and LoveBiome’s microbiome-health operating assets. The acquisition added microbiome-health products and personnel to the platform and expanded its consultant network. Products are provided to customers and independent consultants, who participate in a commission-based direct-sales opportunity.
Operations extend across the Americas, Asia-Pacific, and Europe. The business shifted from retail to direct sales after determining its science-heavy product required explanation, making consultant-led distribution central to the model. Product formulation, labeling, advertising, and related claims remain subject to FDA, FTC, and comparable laws.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Aug 28, 2026 | Lake Street | Reiterate | Rating: —Target: $5 | Target: $6 |
| May 7, 2026 | Lake Street | Downgrade | ||
| Feb 5, 2026 | Loop Capital Markets | Target | Target: — | Target: $5 |
| Feb 5, 2026 | Lake Street | Target | Target: $12 | Target: $5 |
| Nov 5, 2025 | Lake Street | Target | Target: $30 | Target: $12 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $14.9M · Total debt $9.9M · Total assets $62.1M · Shareholders' equity $33.6M
- Revenue
- $42.4M
- Operating income
- $1.7M
- Net income
- $1.3M
HistoryDividendAnnual yield
| Institutions | 47.22% | 5.92M shares | |
|---|---|---|---|
| 95 holders · as of Jun 30, 2026 | |||
| Insiders | 23.74% | 2.97M shares | |
| 15 holders · as of Sep 17, 2026 | |||
| Other | 29.04% | 3.64M shares | |
| remainder | |||
12.53M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Capital Management Corp /VAInstitution | 14.99% | 1.88M | as of Jun 30, 2026 |
The Capital Management CorporationInstitution | 14.99% | 1.88M | filed Jul 6, 2026 |
Steven R. FifeInsiderdirector, officer: President and CEO | 5.87% | 735,471 | filed Apr 3, 2026 |
Bradley L. RadoffInsider | 5.78% | 723,958 | filed May 15, 2023 |
The Vanguard GroupInstitution | 5.69% | 712,453 | filed Feb 10, 2022 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 15, 2026 | Darwin Lewis | director | +976 | $6.22 |
| Sep 14, 2026 | Kristen Cunningham | officer: Chief Sales Officer | −8,901 | $6.18 |
| Sep 11, 2026 | Kristen Cunningham | officer: Chief Sales Officer | −100 | $6.41 |
| Jun 15, 2026 | Darwin Lewis | director | +705 | $8.60 |
| Jun 3, 2026 | Michael A. Beindorff | director | −10,000 | $8.55 |
- Herbalife
Global direct-selling nutrition platform with a Member network
- USANA Health Sciences
Science-based supplements, foods and personal care sold direct
- Nu Skin
Beauty and wellness products sold through person-to-person channels
- Nature's Sunshine Products
Nutritional and personal-care products sold through consultants
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| LifeVantage | $6.06 | −2.57% | $78.5M | 15.5 | 20.9 | 0.4 | −23.1% |
| Herbalife | $11.96 | −2.21% | $1.27B | 7.9 | 4.5 | 0.2 | +5.4% |
| USANA Health Sciences | $14.22 | −3.79% | $272.9M | — | 13.9 | 0.3 | −5.3% |
| Nu Skin | $4.72 | −2.98% | $236.0M | — | 4.9 | 0.2 | −17.1% |
| Nature's Sunshine Products | $13.04 | −1.40% | $232.5M | 13.1 | 12.1 | 0.5 | +2.0% |
| Median | 10.5 | 8.5 | 0.3 | −1.7% |